286 related articles for article (PubMed ID: 35908993)
1. The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.
Tsiropoulos GN; Vallee R; Gallo Castro D; Ambresin A
J Fr Ophtalmol; 2022 Oct; 45(8):852-859. PubMed ID: 35908993
[TBL] [Abstract][Full Text] [Related]
2. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
Inan S; Polat O; Karadas M; Inan UU
Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
[No Abstract] [Full Text] [Related]
3. Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID-19 pandemic lockdowns: A large cohort.
Barequet D; Shor R; Segal O; Greenbaum E; Trivizki O; Loewenstein A; Rabina G
Acta Ophthalmol; 2024 May; 102(3):e322-e327. PubMed ID: 37698269
[TBL] [Abstract][Full Text] [Related]
4. The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol.
Sevik MO; Aykut A; Özkan G; Dericioğlu V; Şahin Ö
Int Ophthalmol; 2021 Sep; 41(9):2951-2961. PubMed ID: 33864577
[TBL] [Abstract][Full Text] [Related]
5. The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown.
Bulut MN; Sönmez HS; Gökçe G; Ağaçkesen A; Bulut K; Hacısalihoğlu A; Arsan A; Şimşek Ş
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102449. PubMed ID: 34314862
[TBL] [Abstract][Full Text] [Related]
6. Pilot study to evaluate the role of high-dose ranibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with persistent/recurrent macular fluid <30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study).
Fung AT; Kumar N; Vance SK; Slakter JS; Klancnik JM; Spaide RS; Freund KB
Eye (Lond); 2012 Sep; 26(9):1181-7. PubMed ID: 22878451
[TBL] [Abstract][Full Text] [Related]
7. Association Between Visual Acuity and Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis.
Patil NS; Mihalache A; Dhoot AS; Popovic MM; Muni RH; Kertes PJ
JAMA Ophthalmol; 2022 Jun; 140(6):611-622. PubMed ID: 35551359
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration.
Szegedi S; Ebner C; Miháltz K; Wachter T; Vécsei-Marlovits PV
BMC Ophthalmol; 2022 May; 22(1):228. PubMed ID: 35596203
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic.
Borrelli E; Grosso D; Vella G; Sacconi R; Battista M; Querques L; Zucchiatti I; Prascina F; Bandello F; Querques G
Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2621-2628. PubMed ID: 33009973
[TBL] [Abstract][Full Text] [Related]
10. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
[TBL] [Abstract][Full Text] [Related]
11. Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Lukacs R; Schneider M; Nagy ZZ; Sandor GL; Kaan K; Asztalos A; Enyedi L; Pek G; Barcsay G; Szabo A; Borbandy A; Kovacs I; Resch MD; Papp A
BMC Ophthalmol; 2023 Mar; 23(1):110. PubMed ID: 36932356
[TBL] [Abstract][Full Text] [Related]
12. OCT Predictors of 3-Year Visual Outcome for Type 3 Macular Neovascularization.
Sacconi R; Forte P; Tombolini B; Grosso D; Fantaguzzi F; Pina A; Querques L; Bandello F; Querques G
Ophthalmol Retina; 2022 Jul; 6(7):586-594. PubMed ID: 35227948
[TBL] [Abstract][Full Text] [Related]
13. Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration.
Chandra S; Arpa C; Menon D; Khalid H; Hamilton R; Nicholson L; Pal B; Fasolo S; Hykin P; Keane PA; Sivaprasad S
Eye (Lond); 2020 Oct; 34(10):1888-1896. PubMed ID: 31980748
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a calculation model to estimate the impact of the COVID-19 pandemic lockdown on visual acuity in neovascular AMD.
Stattin M; Haas AM; Ahmed D; Graf A; Krepler K; Ansari-Shahrezaei S
Eur J Ophthalmol; 2022 Jul; 32(4):2312-2318. PubMed ID: 34726553
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up.
Hosseini H; Rabina G; Pettenkofer M; Au A; Chehaibou I; Heilweil G; Weiner AJ; Ip M; Loewenstein A; Schwartz SD
Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1153-1160. PubMed ID: 33245430
[TBL] [Abstract][Full Text] [Related]
16. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
Brown DM; Chen E; Mariani A; Major JC;
Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
[TBL] [Abstract][Full Text] [Related]
17. Association between structural and functional treatment outcomes in neovascular age-related macular degeneration.
Haji H; Gianniou C; Brynskov T; Sørensen TL; Olsen R; Krogh Nielsen M
Acta Ophthalmol; 2023 Mar; 101(2):177-184. PubMed ID: 36036674
[TBL] [Abstract][Full Text] [Related]
18. [Impact of the French 2020 COVID-19 lockdown on the treatment and follow-up of patients with exudative age-related macular degeneration].
Auger A; Khanna RK; Bonicel P; Pisella PJ; Le Lez ML
J Fr Ophtalmol; 2023 Jun; 46(6):596-604. PubMed ID: 37248127
[TBL] [Abstract][Full Text] [Related]
19. The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens.
Jiang B; Gao L; Dong S; Hou Q; Sun M; Zhang J; Yu H; Zhang Z; Sun D
Adv Ther; 2022 Apr; 39(4):1568-1581. PubMed ID: 34817809
[TBL] [Abstract][Full Text] [Related]
20. Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.
Ohji M; Okada AA; Sasaki K; Moon SC; Machewitz T; Takahashi K;
Graefes Arch Clin Exp Ophthalmol; 2021 Dec; 259(12):3637-3647. PubMed ID: 34283294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
